The roadmap

Where this is going.

Celloxen Insight today reads a single reflection and gives you perspectives on it. Three things we are building. None is available yet, and these words will not change until they are.

Celloxen is a reflective practitioner tool, not a medical, diagnostic or emergency service.

Where it is going

Three things we are building.

None of these is available today. When each is real, this page will describe it as real — and not before.

01

Reading across sessions

Today each reflection stands alone. We are building the ability to read a client’s sessions together — what recurs, what has shifted, what no longer fits. That is a considerably harder problem than reading one session well, and we would rather do it properly than early.

02

Bringing the body into the reflection

What a client says and what their body does are not always the same thing. We are working on a way to bring a simple measure of how settled a person is into the same reflection, taken in the room, in the session, with your consent and theirs. It would show alongside what they told you, never instead of it, and it would remain a description rather than a measurement of anything clinical. It is not built, and we will not describe it as though it were.

03

A calmer client, away from the room

Separately, we are developing a wearable system that helps a person settle physically and shows them it is working. That is a consumer product on its own timeline. It is not part of Celloxen Insight, it does not connect to it today, and we will not market one as though it were the other.

Where it is not going

Some doors we are keeping shut on purpose.

A roadmap is also a set of refusals. These are not caveats we may revisit; they are boundaries the product is built around.

01

We will not diagnose.

Not now, not later, not as an option. Celloxen Insight organises and reflects. It does not assess, measure or classify a person.

02

We will not speak to your client.

The plate is yours. What reaches the person in front of you is your judgment, and that boundary is built into the system rather than settled by policy.

03

We will not claim evidence we do not have.

The perspectives it offers are drawn from scholarship and shown with their standing. Whether the tool improves outcomes is a separate question, and we will not answer it until it has been tested properly.

Intended pricing

£30 per practitioner per month, when the platform is complete.

Shown here as information, beneath the roadmap, rather than as an offer. Nothing is available to buy today.

Working with a small number of practices

Register your interest.

We will be in touch when there is something worth showing you.

Celloxen Insight

A reflective insight platform. A Celloxen brand.